Skip to main content

Cellzome Gets UK Grant for Stem Cell Tools Project

NEW YORK (GenomeWeb News) – Cellzome today said that it will lead a project that has received a €1.1 million ($1.5 million) grant from the UK's Technology Strategy Board to develop tools that better characterize human stem cells.

Heidelberg, Germany-based Cellzome will collaborate with Pfizer's Neusentis unit, the University of Sheffield, and Plasticell on the project, which will use Cellzome's Episphere technology to identify protein "fingerprints" that predict potentially deleterious changes in stem cells. The grant covers two years of funding.

The firm announced earlier this year that it would collaborate with Neusentis on studying epigenetic mechanisms involved in stem cell differentiation.

Cellzome noted that this grant is the third it has received this year leveraging its chemoproteomics platform. The other two include its part in the Blueprint collaboration to decipher epigenomes of the hematopoietic system, under which it will receive €1.2 million, and its efforts in the Orchid project, under which it is using its platform to help identify new treatments for tuberculosis.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.